Cite Filings / CUE / 0001193125-21-043231
Feed Companies Filings Check
Sign in
SC 13G

Amended Statement of Ownership

Cue Biopharma, Inc. · Filed 2021-02-16 · Acc 0001193125-21-043231

Documents 1

  • SC 13G Amended Statement of Ownership , d100462dsc13g.htm

Around this filing

  • 2022-02-10 SC 13G Amended Statement of Ownership
  • 2021-02-18 4 Chief Medical Officer sold 20,274 shares at an average $15.13 ($306,767)
  • 2021-02-18 4/A Chief Medical Officer sold 2,720 shares at $15.07 ($40,980)
  • 2021-02-16 SC 13G Amended Statement of Ownership
  • 2021-02-12 4 Options or other derivatives
  • 2021-02-12 4 Options or other derivatives
  • 2020-02-14 SC 13G Amended Statement of Ownership

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)

Stakes reported in this filing

Stake history · largest stake in each 13D and 13G

  1. 2026-11-16 SCHEDULE 13G · Cormorant Asset Management, LP 9.99%
  2. 2026-11-16 SCHEDULE 13G · BALYASNY ASSET MANAGEMENT L.P. 5.88%
  3. 2026-11-16 SCHEDULE 13G/A · DRIEHAUS CAPITAL MANAGEMENT LLC 4.02%
Loading d100462dsc13g.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…